Cena / výnosy spoločnosti AMAG Pharmaceuticals
Aká je hodnota metriky Cena / výnosy spoločnosti AMAG Pharmaceuticals?
Hodnota metriky Cena / výnosy spoločnosti AMAG Pharmaceuticals, Inc. je 1.57
Aká je definícia metriky Cena / výnosy?
Cena / výnosy (Price to sales ratio) ukazateľ predstavuje cenu spoločnosti v porovnaní s výškou jej tržieb.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Cena / výnosy spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou AMAG Pharmaceuticals
Čomu sa venuje spoločnosť AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Firmy s metrikou cena / výnosy podobnou spoločnosti AMAG Pharmaceuticals
- Hodnota metriky Cena / výnosy spoločnosti Louisiana-Pacific je 1.57
- Hodnota metriky Cena / výnosy spoločnosti Voyager Therapeutics Inc je 1.57
- Hodnota metriky Cena / výnosy spoločnosti SoFi Technologies je 1.57
- Hodnota metriky Cena / výnosy spoločnosti Colfax Corp je 1.57
- Hodnota metriky Cena / výnosy spoločnosti Chevron je 1.57
- Hodnota metriky Cena / výnosy spoločnosti Seagate Technology plc je 1.57
- Hodnota metriky Cena / výnosy spoločnosti AMAG Pharmaceuticals je 1.57
- Hodnota metriky Cena / výnosy spoločnosti Rexnord Electronics and Controls je 1.57
- Hodnota metriky Cena / výnosy spoločnosti Xponential Fitness je 1.57
- Hodnota metriky Cena / výnosy spoločnosti Religare Enterprises je 1.57
- Hodnota metriky Cena / výnosy spoločnosti Aviva Plc je 1.57
- Hodnota metriky Cena / výnosy spoločnosti Atul Auto je 1.57
- Hodnota metriky Cena / výnosy spoločnosti The South Indian Bank je 1.57